Log Type Authored on Log Message Log Node Authored by
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Gäst
User created User created Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Apoio à saúde mental em tempos de crise Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter clicked Clicked https://za.progress.im/en/content/expert-view-page-0 Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/por-que-enxaqueca-n%C3%A3o-%C3%A9-apenas-uma-forte-dor-de-cabe%C3%A7a Apoio à saúde mental em tempos de crise Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened É Amanhã! Convite Lundbeck Webinar Internacional Gäst
Newsletter opened Opened Apoio à saúde mental em tempos de crise Gäst
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://za.progress.im/en/event/covid-19-south-africa Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter clicked Clicked https://za.progress.im/en/event/covid-19-south-africa Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Gäst
Log Type Authored on Log Message Log Node Authored by
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Gäst
User created User created Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Apoio à saúde mental em tempos de crise Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter clicked Clicked https://za.progress.im/en/content/expert-view-page-0 Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/por-que-enxaqueca-n%C3%A3o-%C3%A9-apenas-uma-forte-dor-de-cabe%C3%A7a Apoio à saúde mental em tempos de crise Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened É Amanhã! Convite Lundbeck Webinar Internacional Gäst
Newsletter opened Opened Apoio à saúde mental em tempos de crise Gäst
Newsletter clicked Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://za.progress.im/en/event/covid-19-south-africa Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter clicked Clicked https://za.progress.im/en/event/covid-19-south-africa Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Gäst
Newsletter opened Opened Gäst